v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Beginning balance, value at Dec. 31, 2024 $ 17,610 $ 6 $ 139,480 $ 48 $ (121,924)
Beginning balance (in shares) at Dec. 31, 2024   59,235,000      
Issuance of common stock in connection with at-the-market offering, net of issuance costs (28) (28)
Issuance of common stock in connection with at-the-market offering, net of issuance costs (in shares)   9,000      
Stock-based compensation expense 350 350
Foreign currency translation adjustments (6) (6)
Net loss (6,302) (6,302)
Ending balance (in shares) at Mar. 31, 2025   59,244,000      
Ending balance, value at Mar. 31, 2025 11,624 $ 6 139,802 42 (128,226)
Beginning balance, value at Dec. 31, 2025 $ 15,730 $ 8 164,225 30 (148,533)
Beginning balance (in shares) at Dec. 31, 2025 76,428,000 76,428,000      
Issuance of common stock to related party in connection with 2025 Private Sales Transactions $ 5,650 5,650
Issuance of common stock to related party in connection with 2025 Private Sales Transactions (in shares)   5,179,000      
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs 2,174 2,174
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs (in shares)   1,689,000      
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs 1,997 1,997
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs (in shares)   1,351,000      
Stock-based compensation expense 312 312
Foreign currency translation adjustments 2 2
Net loss $ (6,780) (6,780)
Ending balance (in shares) at Mar. 31, 2026 84,648,000 84,647,803      
Ending balance, value at Mar. 31, 2026 $ 19,085 $ 8 $ 174,358 $ 32 $ (155,313)